Header Logo

Connection

SALIM VIRANI to Factor Xa Inhibitors

Back to Details
This is a "connection" page, showing publications SALIM VIRANI has written about Factor Xa Inhibitors.
SALIM VIRANI
Connection Strength
0.675
Factor Xa Inhibitors
  1. Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
    View in: PubMed
    Score: 0.675
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.